A federal appeals court recently upheld misdemeanor convictions of two former executives of Acclarent Inc, a medical device manufacturer, for commercially distributing an adulterated and misbranded medical device by misleading the FDA regarding the intended use of the device. In United States v. Facteau (89 F.4th 1 (1st Cir. 2023)) the First Circuit Court of
February 2024
Private Equity and Healthcare Consolidation: The Revolution in Antitrust Enforcement
The healthcare sector is witnessing a trend toward consolidation, but it’s not just big hospital mergers making headlines. Private equity is playing a pivotal role in driving smaller consolidations within healthcare provider services.
In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell talks to McGuireWoods antitrust partner Holden Brooks about the role of private…
New Jersey Becomes the Latest State to Enact a Comprehensive Data Privacy Law
On January 16, 2024, New Jersey became the thirteenth state to enact a comprehensive data privacy law, named the New Jersey Data Privacy Act (the “NJDPA”).
The NJDPA, which will take effect on January 15, 2025, includes some provisions that are different from other data privacy laws, thereby requiring entities that fall within its scope…
Healthcare & Life Sciences Private Equity Deal Tracker: HealthEdge Invests in Radsource
HealthEdge Investment Partners recently announced an investment in Radsource.
Radsource, based in Brentwood, Tenn., is a provider of subspecialty orthopedic and neurological MRI interpretations. Founded in 2001, the company is also known for its medical imaging technology solution, ProtonPACS, which it launched through a partnership with Intelerad.
HealthEdge, based in Tampa, Fla., makes…
The Appraisal Clause: What It Is, and When to Enforce It
The Appraisal Process
Even when an insurer agrees to cover an insurance claim, disputes often arise between the insurer and the insured as to the valuation of the loss, particularly for claims under commercial property and business interruption policies. In these circumstances, policyholders should consider whether and to what extent the dispute could be resolved…
Private Equity Interest in Cardiology, With Tim Attebery of Cardiovascular Associates of America
The consolidation wave of private equity-backed platforms has moved through different sectors at different times. One of the most recent sectors to see increased interest from private equity is cardiology.
This episode of The Corner Series introduces the “Executive Corner,” where McGuireWoods’ Geoff Cockrell is joined by Tim Attebery, CEO of Cardiovascular Associates of America…
The Foreign Extortion Prevention Act: Another Tool to Fight Foreign Corruption
In recent years, the Biden Administration has been vocal that combatting foreign public corruption is a key pillar of its national security efforts.[1] Consistent with those policy goals, on December 22, 2023, Congress passed the Foreign Extortion Prevention Act (FEPA), a long-awaited complement to the Foreign Corrupt Practices Act (FCPA). Where the FCPA…
New York LLC Transparency Act Beneficial Ownership Reporting Requirements to Take Effect
On December 23, 2023, New York Governor Kathy Hochul signed the New York LLC Transparency Act (“NYLTA”), which requires LLCs to disclose beneficial ownership information (“BOI”) to the New York Department of State. Effective December 21, 2024, the NYLTA will impose separate BOI reporting requirements on New York LLCs, which are also subject to the…
Healthcare & Life Sciences Private Equity Deal Tracker: Peloton Equity Leads Investment in OnPoint Healthcare Partners
Peloton Equity has announced it led a growth investment in OnPoint Healthcare Partners. Joining Peloton in the investment was Fort Maitland Capital.
OnPoint, founded in 2020 and based in Dallas, is a healthcare technology company offering solutions intended to help address physician burnout and optimize financial and operational efficiency of provider organizations.
Peloton,…
Windjammer Capital Closes Fund With $1.3 Billion
Windjammer Capital Investors has announced it has closed its latest fund at $1.3 billion in commitments.
The new fund, Windjammer Capital Fund VI, exceeded its $1 billion initial target.
Windjammer, based in Newport Beach, Calif., and Waltham, Mass., is a private equity firm focused on the middle market. Founded in 1990, the firm prefers…